hpv
No description yet: the sentence for this tag has not been written. 8 records carry it: 4 people, 4 cancers.
Related tags
8 records
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Anal cancer (squamous cell carcinoma) An HPV-caused cancer of the anal canal that is usually cured without surgery by combined chemotherapy and radiation. Prevention (HPV vaccination, screening of high-risk groups) and immunotherapy for advanced disease are the new fronts. | none | none | gastrointestinal | ||
Mark Schiffman Senior Investigator, Division of Cancer Epidemiology and Genetics, National Cancer Institute · National Cancer Institute (NIH) NCI epidemiologist whose HPV natural history studies underpin HPV-based cervical screening and risk-based management worldwide. | Cervical cancer | none | screening, epidemiology | ||
Maura L. Gillison Professor of Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center · MD Anderson Cancer Center Established that HPV causes a distinct, better-prognosis form of throat cancer and led RTOG 1016 on how to treat it. | Head and neck squamous cell carcinoma | none | head-and-neck, de-escalation | ||
Nubia Muñoz Emeritus Professor, National Cancer Institute of Colombia; former Chief of Field and Intervention Studies, IARC · Instituto Nacional de Cancerología (Colombia) Colombian epidemiologist whose IARC studies proved HPV causes cervical cancer and identified the types the vaccines target. | Cervical cancer | none | epidemiology, prevention, latin-america | ||
Penile cancer Penile cancer is a squamous skin-type cancer, about half of it caused by HPV. Caught early it is usually cured with organ-sparing surgery that has replaced amputation, and HPV vaccination and circumcision prevent it; the hard cases are those with lymph-node spread, where cisplatin-based chemotherapy plus surgery and now immunotherapy are being tested in the InPACT trial. | none | none | rare, genitourinary | ||
Peter Sasieni Professor of Cancer Epidemiology, Queen Mary University of London; Director, Cancer Prevention Trials Unit · Barts Cancer Institute / Barts Health NHS Trust Epidemiologist who showed HPV vaccination has nearly eliminated cervical cancer in vaccinated English women and leads NHS-Galleri. | Cervical cancer | none | screening, prevention | ||
Vaginal cancer Primary vaginal cancer is rare and mostly caused by HPV, the virus behind cervical cancer. It is treated like cervical cancer, with weekly cisplatin alongside external and internal radiotherapy, which controls most tumours while preserving the organ; HPV vaccination and cervical screening, which also detects vaginal precursors, are steadily reducing it. | none | none | rare, gynaecologic | ||
Vulvar cancer An uncommon cancer of the external genitalia with two distinct causes: HPV infection in younger women and chronic skin inflammation in older women. Surgery is the mainstay, and sentinel-node biopsy has made it far less mutilating. | none | none | gynaecologic |